echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Zhejiang will complete the first dose of 23.4 million people before the end of April!

    Zhejiang will complete the first dose of 23.4 million people before the end of April!

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    At 10:00 am on April 2, the 70th press conference on the prevention and control of the new coronavirus pneumonia in Zhejiang Province was held.


    01

    Two new asymptomatic cases in Zhejiang yesterday

    At 04:00 on April 1, 2 cases of asymptomatic infections were newly added in Zhejiang (including 1 case imported from Turkey and 1 case imported from Indonesia), and all close contacts who have been investigated have been quarantined.


    infection

    According to news from Health Jinhua, there were no new confirmed cases of new coronary pneumonia in Jinhua City from 0-24 o'clock on April 1, and 1 new case of asymptomatic infection (1 case in Yiwu City, imported from abroad).


    Coronavirus disease

    Newly added asymptomatic infection: asymptomatic infection, male, Turkish nationality.


    diagnosis

    02

    It is recommended that the local staff in Ruili postpone their visit to Zhejiang

    Recently, Ruili City, Yunnan Province has newly confirmed a number of local confirmed cases.


    The city implemented global closed management on March 31, and five places including Jiejiao Guomen Community were classified as medium risk areas on April 1.


    management

    According to the relevant regulations of Zhejiang Province's normalized epidemic prevention and control mechanism, the “7+7” health management measures will be implemented for those returning to Zhejiang who are still moving across provinces during the closed management period of Ruili City, that is, a 7-day centralized quarantine medicine will be implemented.


    03

    Zhejiang has completed 6,781,500 doses of new crown vaccination

    As of April 1, Zhejiang Province has completed 6,781,500 doses of new coronavirus vaccination, including the first dose of 5.


    It is understood that Zhejiang, as the country's first key province to promote new crown virus vaccination, must complete the first dose of 23.


    Chen Guangsheng, executive deputy director of the Office of Zhejiang Provincial Leading Group for Prevention and Control Work and deputy secretary-general of the provincial government, said that Zhejiang requires government agencies and cadres to take the lead to promote the general vaccination of personnel in enterprises, institutions, universities, and medical institutions.


    immunity

    04

    Domestic epidemic control is better

    Why mass vaccination

    Question: The domestic epidemic has now been controlled relatively well.


    Answer: Vaccination is the most effective means to prevent and control infectious diseases.


    prevention

    Studies have shown that even in the face of mutated new coronaviruses, current vaccines still have a defensive effect.


    There is a point of view that it took only more than 300 days from the establishment of the domestic new coronavirus vaccine to the research and development, production, and marketing.


    The provincial party committee and the provincial government attach great importance to the safe vaccination of the new coronavirus vaccine and require the establishment of a strict full-chain supervision and service mechanism.


    Question: We have learned that large-scale vaccination of the new crown virus is being initiated across the country.


    Answer: According to the unified deployment of the State Council's joint prevention and control mechanism, our province has started large-scale vaccinations against the new coronavirus.
    Currently, there are two main aspects of our work:

    Carry out special actions to investigate risk links.

    Our bureau attaches great importance to the supervision of the quality and safety of the new crown virus vaccine.
    The main person in charge has held several special meetings and researches to comprehensively sort out the current situation and management requirements of the whole process and the whole chain of the new crown virus vaccine, carefully find the risk points, conduct risk analysis and judgment, and Make targeted deployments.
    Formulate and issue a special action plan to clearly require strengthening the quality supervision of the new coronavirus vaccine, carrying out daily inspections and inspections, and strictly investigating and punishing violations of vaccine storage and transportation management regulations, illegal supply of vaccines, and illegal production and sale of fake and inferior vaccines.

    Improve the working mechanism and weave a dense supervision network.

    The first is to implement risk management and establish a monthly report system and daily inspection mechanism for the new crown vaccine research and development unit.
    Carry out irregular inspections of R&D units, form an information reporting system for daily work monthly reports, important work semi-monthly reports, and immediate reports on major situations, to follow up the progress of enterprise research and development in a timely manner, and to supervise relevant units to do a good job in the storage and use management of samples, and implement them Subject responsibility.

    The second is to carry out weekly inspections of storage, transportation and use links.
    With vaccine storage, transportation and vaccination as the focus of supervision, organize and carry out the full coverage inspection of the province's new crown virus vaccine storage and distribution enterprises, and implement "one-week inspections" on the province's vaccination units.

    The third is to establish an Internet information monitoring system.
    A total of more than 110,000 online sales entities on Alibaba, Youzan.
    com, JD.
    com, Meituan, Ele.
    me, Pinduoduo and other Internet platforms have been thoroughly investigated and monitored to prevent illegal information and transactions of new crown pneumonia vaccines on the platforms.
    Interview with third-party platforms for drug online sales, requiring third-party platforms to strengthen information monitoring and clearance, and promptly discover and process illegal information.

    The fourth is to organize and carry out special supervision on the quality supervision of the new coronary pneumonia vaccine.
    Supervise all localities to implement the local supervision responsibility of the new crown pneumonia vaccine, and make the purchase channel of the new crown virus vaccine, the inspection and acceptance link, the storage and transportation link, the information recording and upload link, and the disposal link of the discarded vaccine as the focus of the special inspection work.
    The province inspected a total of 3,811 seedling-related units, of which 360 were temporary vaccination sites, and 221 units were found to be problematic, all of which have been supervised and rectified in place.

    05

    Zhejiang will push the "Zhe Miao Chain"

    Realize the traceability of the source of the whole vaccine process

    Question: Our province is comprehensively advancing the digital reform.
    Does the province have any consideration in using digital means to carry out the quality supervision of the new crown vaccine?

    Answer: At present, we are developing a traceability supervision system for the whole chain of vaccines in Zhejiang Province, the "Zhejiang Miao Chain" system.
    The "Zhe Miao Chain" is to build a traceability system for integrated closed-loop management of vaccines, to realize the traceability of the source, whereabouts, traceability, controllable risks, accountability, and public inspection of vaccines in the whole province from production to circulation and vaccination.

    The first phase of the project mainly realizes four major functions:

    One is the traceability of the process.
    Through the product data and temperature data of the whole process of vaccine production, storage, distribution, and vaccination, it can quickly locate the cold chain status of the vaccine in the circulation process, and realize the source of vaccine data in the whole province can be checked and whereabouts can be traced.

    Second, the risk is controllable.
    Through the analysis of the production information, storage and transportation information, temperature data, use conditions and other dynamic information of the vaccine in the production, circulation, and vaccination process in the province, risk information is automatically generated and provided to the supervisory authority to strengthen risk management capabilities and realize the entire province’s vaccines Directional and three-dimensional supervision.

    The third is responsibility.
    Through real-time docking with the National Vaccine Traceability Supervision Collaboration Platform, and timely receipt of product recall information issued by the State Food and Drug Administration, we can quickly realize the precise traceability control of the number of recalled vaccines in question , and implement the main responsibility of the enterprise.

    Precise

    Fourth, it can be checked by the public.
    Connecting with Zhezheng Ding, Zheli Office and other systems, by scanning the vaccine traceability code, the public can inquire about the vaccine's product information, circulation and distribution, storage temperature and other related information, effectively guaranteeing the public's right to know the vaccines being vaccinated.

     



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.